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Competition for organic anion
transporters in chronic renal
disease
To the Editor: In their mini review, Meyer and Hostetter1
review recent evidence that uremic toxins such as indoxyl
sulfate and p-cresyl sulfate are produced by colonic bacteria
and suggest that suppressing their production might beneﬁt
patients with renal failure.
Evidence that uremic solutes are secreted, rather than
ﬁltered, using organic anion transporters2,3 may create a new
paradigm in treating patients with chronic renal failure.
Smith wrote, ‘In tubular excretiony apparently all substances
share a common element in one of two transport systemsy
This is presumably a result of competitiony since it is freely
reversible’.4 The possibility that many drugs compete for the
secretion of indoxyl sulfate or other uremic toxins broadens
greatly the range of drugs that should be used with caution in
patients with uremia or less-advanced stages of renal failure.
Rather than focus on guidelines that depend on estimated
glomerular ﬁltration rate, prescribing for patients with
chronic renal failure should take into consideration possible
competition for organic anion transport.
1. Meyer T, Hostetter T. Uremic solutes from colon microbes. Kidney Int 2011;
81: 949–954.
2. Sekine T, Cha SH, Endou H. The multispecific organic anion transporter
(OAT1) family. Plugers Archiv-Eur J Physiol 2000; 440: 337–350.
3. Lowenstein J. The anglerfish and uremic toxins. FASEB J 2011; 25:
1782–1785.
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The Authors Reply: Like Dr Lowenstein,1 we are intrigued
by the possibility that impaired secretion of toxic compounds
contributes to uremic illness. Competition for tubular
transport may cause both natural waste solutes and
pharmaceutical metabolites to accumulate out of proportion
to the reduction in glomerular ﬁltration rate (GFR). As Dr
Lowenstein notes, the assumption that some of these secreted
compounds are toxic can explain why uremic symptoms are
not closely correlated with creatinine and other GFR markers.
James Shannon, a student of Homer Smith, who became
Director of the NIH, raised these points many years ago and
concluded, ‘The answer to this question must await the
further identiﬁcation of those substances which make up the
unknown portion of the urinary constituents’.2 So far,
however, we have compiled only a limited catalog of secreted
compounds and know very little about their individual effects.
In addition to their transport across the renal tubules, the
transport of organic ions across other barriers may be involved
in uremic illness. For example, hepatic clearance of some drugs
is reduced in end-stage renal disease patients due at least in
part to impaired hepatic transport of organic ions.3 Impaired
organic ion transport across the blood–brain barrier could
contribute to uremic encephalopathy.4 The organic ion trans-
porters are widely distributed and the accumulation of trans-
ported solutes due to kidney failure could therefore interfere
with multiple physiological processes.
1. Lowenstein J. Competition for organic anion transporters in chronic renal
disease. Kidney Int 2012; 82: 1033.
2. Shannon JA. Renal tubular excretion. Physiol Rev 1939; 19: 63–93.
3. Nolin TD, Frye RF, Le P et al. ESRD impairs nonrenal clearance of
fexofenadine but not midazolam. J Am Soc Nephrol 2009; 20: 2269–2276.
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Interstitial mononuclear infiltrates
in murine a3(IV)-NC1–induced
nephropathy: harbingers of renal
failure?
To the Editor: Whereas the noncollagenous domain 1 of
a3(IV) collagen (a3(IV)-NC1) is the major target of Good-
pasture autoantibodies in anti-glomerular basement mem-
brane (GBM) glomerulonephritis, DBA/1 mice immunized
with a3(IV)-NC1 develop massive albuminuria progressing to
nephrotic syndrome. Kidney histopathology shows ﬁne granular
GBM deposition of immunoglobulin G and C3, GBM thick-
ening with ‘spike’ reaction, subepithelial electron-dense deposits,
and podocyte foot process effacement, but minimal glomer-
ular inﬂammation.1–3 These clinical and morphological ﬁndings
recapitulate human membranous nephropathy rather than
anti-GBM glomerulonephritis. This unexpected phenotype
may be due to a subepithelial planted antigen, consistent with
the ﬁne granular deposition of exogenous antigen in the
capillary loops.3 An elegant recent study comprehensively
characterized tubulointerstitial inﬁltrates of macrophages and
CD4(þ ) T helper (Th)1 and Th17 cells in the late stages of
a3(IV)-NC1–induced nephropathy.1 This may reﬂect a true
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autoimmune response against a3(IV) collagen occurring in
all mouse (but not human) tubular basement membranes.
Alternatively, mononuclear interstitial inﬁltrates may be
secondary to nephrotic-range proteinuria. Of note, the pre-
dominant inﬂammatory cells in human membranous nephro-
pathy are interstitial monocytes/macrophages and CD4(þ )
T cells.4 Moreover, their numbers correlate with renal impair-
ment at the time of biopsy and progressive renal impairment
over 5 years, suggesting that progression toward renal failure
in membranous nephropathy may be driven mainly by cell-
mediated immunity.4 Future studies expanding on the ﬁndings
of Hopfer et al. are needed to determine whether interstitial
mononuclear inﬁltrates are indeed harbingers of renal failure
in membranous nephropathy.
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The Authors Reply: In their letter1 and in a recent publica-
tion,2 Borza and Fogo report that DBA/1 mice immunized
twice with recombinant human noncollagenous domain 1 of
a3(IV) collagen (a3(IV)-NC1) developed severe nephrotic
syndrome. Histological examination revealed membranous
glomerulonephritis (GN) with only a few glomerular crescents.
The protocol deployed in our studies3,4 uses four immuniza-
tions instead of two. After a stage of membranous GN, mice
rapidly progress to a necrotizing crescentic GN accompanied
by tubulointerstitial damage with massive inﬁltration of
macrophages and, to a lesser extent, T cells. In our study, two
immunizations were also not sufﬁcient to induce crescentic
GN (unpublished). Thus, continuous immunizations appear
to be necessary for the switch to crescentic GN.
Borza and Fogo suggest that the interstitial inﬁltrates may
be a true autoimmune response against mouse tubular base-
ment membranes. In contrast, we favor the hypothesis that
a3IV-NC1–speciﬁc T cells are the driving force triggering the
switch from membranous to crescentic GN. As recently pro-
posed by Heymann et al.,5 antigen from damaged glomeruli
may spread into the interstitium and become available for
antigen presentation, causing local T-cell activation and sub-
sequent recruitment and activation of macrophages. We think
that this mechanism is more likely because the glomerular
basement membranes show extensive alterations while the
tubular basement membranes don’t. In our view, the biphasic
course of our animal model with a rapid increase of mononu-
clear cells in the context of crescentic GN rather than a chronic
accumulation does not support the concept of mononuclear
cells as a harbinger of renal failure in membranous GN.
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Association between dialysis
schedule and mortality in
maintenance hemodialysis
To the Editor: This is with reference to the recent article by
Zhang et al.1 that studied the association between the dialysis
schedule and the day of the week of all-cause mortality in
maintenance hemodialysis (HD) patients. We undertook a
retrospective analysis of all chronic HD patients (treated for
46 months) dialyzed in a single UK region (Northern
Ireland, population¼ 1.8 million) in order to study this
relationship. All deaths between 2007 and 2011 were recorded
(n¼ 247; mean age¼ 70.2 years; 62.7% males). The mean
duration of HD was 55 months (range 6–296 months) and
the commonest primary renal diagnosis was diabetic
nephropathy (22%). We found a relative increase in mortality
on the ﬁrst dialysis schedule day, i.e., Monday for
Monday–Wednesday–Friday (MWF) schedule and Tuesday
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